COL1A2 and osteogenesis imperfecta: Our study aims to expand the genetic and clinical spectrum of OI by identifying rare PVs in the commonly implicated COL1A1 and COL1A2 as well as in other genes involved in collagen metabolism, osteoblast differentiation, and bone mineralization.